These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 33456581)

  • 21. Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells.
    Lee CH; Hong HM; Chang YY; Chang WW
    Biochimie; 2012 Jun; 94(6):1382-9. PubMed ID: 22445681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 23. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
    Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
    Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
    Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
    Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.
    Prabhu VV; Allen JE; Dicker DT; El-Deiry WS
    Cancer Res; 2015 Apr; 75(7):1423-32. PubMed ID: 25712124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway.
    Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y
    Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis.
    Feng Y; Dai X; Li X; Wang H; Liu J; Zhang J; Du Y; Xia L
    Cell Prolif; 2012 Oct; 45(5):413-9. PubMed ID: 22925500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
    Shankar S; Nall D; Tang SN; Meeker D; Passarini J; Sharma J; Srivastava RK
    PLoS One; 2011 Jan; 6(1):e16530. PubMed ID: 21304978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heat shock proteins in cancer stem cell maintenance: A potential therapeutic target?
    Lettini G; Lepore S; Crispo F; Sisinni L; Esposito F; Landriscina M
    Histol Histopathol; 2020 Jan; 35(1):25-37. PubMed ID: 31322279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway.
    Green R; Howell M; Khalil R; Nair R; Yan J; Foran E; Katiri S; Banerjee J; Singh M; Bharadwaj S; Mohapatra SS; Mohapatra S
    Sci Rep; 2019 Dec; 9(1):18177. PubMed ID: 31796785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation.
    Boothello RS; Patel NJ; Sharon C; Abdelfadiel EI; Morla S; Brophy DF; Lippman HR; Desai UR; Patel BB
    Mol Cancer Ther; 2019 Jan; 18(1):51-61. PubMed ID: 30337351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells.
    Quarni W; Dutta R; Green R; Katiri S; Patel B; Mohapatra SS; Mohapatra S
    Sci Rep; 2019 Oct; 9(1):15202. PubMed ID: 31645574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.
    Zhou H; Yu C; Kong L; Xu X; Yan J; Li Y; An T; Gong L; Gong Y; Zhu H; Zhang H; Yang X; Li Y
    Oncogene; 2019 May; 38(18):3371-3386. PubMed ID: 30635656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
    Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
    Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
    Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting cancer stem cells expressing an embryonic signature with anti-proteases to decrease their tumor potential.
    Darini CY; Martin P; Azoulay S; Drici MD; Hofman P; Obba S; Dani C; Ladoux A
    Cell Death Dis; 2013 Jul; 4(7):e706. PubMed ID: 23828569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
    Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
    Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.